Cost-effectiveness analyses are important because in health economics and outcomes research, we wrestle with the following questions in our health care systems:
Can the health system support the additional cost for each life saved if the new drug is both more costly and more effective than previous therapies?
• If a new drug or device is less costly, but less effective, than existing therapies, how much of a diminution in efficacy can society/payers/patients withstand in order to save money?
• How much money must be saved in order to make it "cost-effective" to accept a reduction in efficacy over existing strategies?
At the completion of this online learning module, you will be able to:
• State the role of cost-effectiveness analysis (CEA) and cost-utility analysis (CUA) in medical decision-making
• Define the components of CEA and CUA and understand the computations involved in both
• Understand the concerns in attribution of cost components to a particular treatment arm
The access period once enrolled into the course is 30
days from the date of purchase. After this duration, you will need to
re-enroll if you wish to re-enter the course.
Time to complete – approximately 1 hour